![Pascale Bouillé](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pascale Bouillé
Amministratore Delegato presso FlashCell SAS
Posizioni attive di Pascale Bouillé
Società | Posizione | Inizio | Fine |
---|---|---|---|
FlashCell SAS
![]() FlashCell SAS BiotechnologyHealth Technology FlashCell SAS produces lentiviral vectors to develop gene therapy and immunotherapy programs for therapeutic purposes. The company was founded on August 12, 2016 and is headquartered in Toulouse, France. | Amministratore Delegato | - | - |
Storia della carriera di Pascale Bouillé
Precedenti posizioni note di Pascale Bouillé
Società | Posizione | Inizio | Fine |
---|---|---|---|
Flash Therapeutics SAS
![]() Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Amministratore Delegato | 01/01/2005 | 01/01/2023 |
Presidente | 01/01/2005 | 01/01/2023 | |
Fondatore | 01/01/2005 | 01/01/2023 |
Statistiche
Distribuzione geografica
Francia | 3 |
Posizioni
Chief Executive Officer | 2 |
Chairman | 1 |
Founder | 1 |
Settori
Commercial Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Flash Therapeutics SAS
![]() Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Commercial Services |
FlashCell SAS
![]() FlashCell SAS BiotechnologyHealth Technology FlashCell SAS produces lentiviral vectors to develop gene therapy and immunotherapy programs for therapeutic purposes. The company was founded on August 12, 2016 and is headquartered in Toulouse, France. | Health Technology |
- Borsa valori
- Insiders
- Pascale Bouillé
- Esperienza